Agile Therapeutics, Inc. (AGRX): Price and Financial Metrics


Agile Therapeutics, Inc. (AGRX)

Today's Latest Price: $2.88 USD

0.08 (2.86%)

Updated Sep 25 4:00pm

Add AGRX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 233 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

AGRX Daily Price Range
AGRX 52-Week Price Range

AGRX Stock Price Chart Technical Analysis Charts


AGRX Price/Volume Stats

Current price $2.88 52-week high $4.77
Prev. close $2.80 52-week low $0.35
Day low $2.78 Volume 977,874
Day high $2.89 Avg. volume 2,536,539
50-day MA $2.91 Dividend yield N/A
200-day MA $2.74 Market Cap 251.42M

Agile Therapeutics, Inc. (AGRX) Company Bio


Agile Therapeutics, Inc. focuses on the development and commercialization of prescription contraceptive products for women. The company was founded in 1997 and is based in Princeton, New Jersey.


AGRX Latest News Stream


Event/Time News Detail
Loading, please wait...

AGRX Latest Social Stream


Loading social stream, please wait...

View Full AGRX Social Stream

Latest AGRX News From Around the Web

Below are the latest news stories about Agile Therapeutics Inc that investors may wish to consider to help them evaluate AGRX as an investment opportunity.

Agile Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

PRINCETON, N.J., Sept. 22, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Chairman and CEO Al Altomari will be virtually presenting at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on Wednesday, September 23, 2020 at 3:20 PM EDT. A live webcast of the presentation will be available in the Events and Presentations section of the Investor Relations page or by clicking here. The archived webcast will be available on the Company’s website for 30 days.About Agile Therapeutics, Inc. Agile Therapeutics is a women's healthcare company dedicated to fulfilling the unmet health needs of today’s women.  Our product candidates are designed to provide women with contraceptive options that offer freedom fr...

Yahoo | September 22, 2020

Stocks To Watch: All Eyes On Tesla Battery Day

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking...

SA Stocks To Watch on Seeking Alpha | September 19, 2020

Agile Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 22nd Annual Global Investment Virtual Conference

PRINCETON, N.J., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today announced that Al Altomari, Chairman and Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright 22nd Annual Global Investment Virtual Conference on Wednesday, September 16, 2020 at 11:30 a.m. EDT. A live webcast of the fireside chat will be available in the Events and Presentations section of the Investor Relations page or by clicking here. The archived webcast will be available on the Company's website for 30 days.About Agile Therapeutics, Inc. Agile Therapeutics is a women's healthcare company dedicated to fulfilling the unmet health needs of today’s women.  Our product candidates are designed to provid...

Yahoo | September 9, 2020

Agile Therapeutics Announces Virtual Investor/Analyst Day on Monday, September 21, 2020

Company to Present Twirla® Commercial Plan Webcast Scheduled from 11:00 am – 1:00 pm EDT PRINCETON, N.J., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Agile…

GlobeNewswire | September 8, 2020

Agile Therapeutics: Taking A Victory Lap While We Wait For Twirla's Commercial Launch

Agile Therapeutics (AGRX) struggled for years to get their once-weekly contraceptive patch, Twirla, approved by the FDA. Twirla received two CRLs from the FDA, which pummeled the share price into penny stock status, and investors' sentiment was abysmal. For two years, it looked as if the FDA was not going...

Biologics on Seeking Alpha | September 1, 2020

Read More 'AGRX' Stories Here

AGRX Price Returns

1-mo -3.36%
3-mo 2.13%
6-mo 33.95%
1-year 157.14%
3-year -33.02%
5-year -58.50%
YTD 15.20%
2019 331.03%
2018 -78.44%
2017 -52.81%
2016 -41.60%
2015 58.96%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8238 seconds.